Scibase AB (Sweden) Insiders
| SCIB Stock | SEK 0.39 0.04 11.43% |
Scibase AB employs about 21 people. The company is managed by 6 executives with a total tenure of roughly 28 years, averaging almost 4.0 years of service per executive, having 3.5 employees per reported executive. Breaking down Scibase AB's management performance can provide insight into the firm performance.
| Simon Grant CEO CEO Pres |
Scibase |
Scibase AB Management Team Effectiveness
The company has return on total asset (ROA) of (0.4288) % which means that it has lost $0.4288 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8992) %, meaning that it generated substantial loss on money invested by shareholders. Scibase AB's management efficiency ratios could be used to measure how well Scibase AB manages its routine affairs as well as how well it operates its assets and liabilities.Scibase AB Workforce Comparison
Scibase AB is currently regarded as top stock in number of employees category among its peers. The total workforce of Diagnostics & Research industry is at this time estimated at about 178. Scibase AB retains roughly 21.0 in number of employees claiming about 12% of equities under Diagnostics & Research industry.
The company has Profit Margin (PM) of (2.41) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.59) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.59. Scibase AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Scibase AB Price Series Summation is a cross summation of Scibase AB price series and its benchmark/peer.
Scibase AB Notable Stakeholders
A Scibase AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Scibase AB often face trade-offs trying to please all of them. Scibase AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Scibase AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Simon Grant | CEO Pres | Profile | |
| Stig Ollmar | Founder, Chief Scientific Officer, Director, Inventor | Profile | |
| Tobias Bergenblad | Global Sales Manager | Profile | |
| Per Svedenhag | Head of Business Development and Marketing | Profile | |
| Michael Colrus | Chief Officer | Profile | |
| Linn Olsen | Head Production | Profile |
About Scibase AB Management Performance
The success or failure of an entity such as Scibase AB often depends on how effective the management is. Scibase AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Scibase management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Scibase management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
SciBase Holding AB , a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and internationally. The company was founded in 1998 and is headquartered in Stockholm, Sweden. Scibase Holding operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people.
Please note, the imprecision that can be found in Scibase AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Scibase AB. Check Scibase AB's Beneish M Score to see the likelihood of Scibase AB's management manipulating its earnings.
Scibase AB Workforce Analysis
Traditionally, organizations such as Scibase AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Scibase AB within its industry.Scibase AB Manpower Efficiency
Return on Scibase AB Manpower
| Revenue Per Employee | 558.4K | |
| Revenue Per Executive | 2M | |
| Net Loss Per Employee | 2M | |
| Net Loss Per Executive | 7M | |
| Working Capital Per Employee | 4.6M | |
| Working Capital Per Executive | 16M |
Additional Tools for Scibase Stock Analysis
When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.